Detalhe da pesquisa
1.
CAR-T cell expansion platforms yield distinct T cell differentiation states.
Cytotherapy
; 2024 Mar 12.
Artigo
Inglês
| MEDLINE | ID: mdl-38625071
2.
Immunohistochemical detection of PAX-FOXO1 fusion proteins in alveolar rhabdomyosarcoma using breakpoint specific monoclonal antibodies.
Mod Pathol
; 34(4): 748-757, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33299109
3.
Preclinical Evaluation of the FGFR-Family Inhibitor Futibatinib for Pediatric Rhabdomyosarcoma.
Cancers (Basel)
; 15(16)2023 Aug 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37627061
4.
A stem cell epigenome is associated with primary nonresponse to CD19 CAR T cells in pediatric acute lymphoblastic leukemia.
Blood Adv
; 7(15): 4218-4232, 2023 08 08.
Artigo
Inglês
| MEDLINE | ID: mdl-36607839
5.
Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma.
Cell Rep Med
; 4(10): 101212, 2023 10 17.
Artigo
Inglês
| MEDLINE | ID: mdl-37774704
6.
Synthetic lethal screen identifies NF-κB as a target for combination therapy with topotecan for patients with neuroblastoma.
BMC Cancer
; 12: 101, 2012 Mar 21.
Artigo
Inglês
| MEDLINE | ID: mdl-22436457
7.
FGFR4-Targeted Chimeric Antigen Receptors Combined with Anti-Myeloid Polypharmacy Effectively Treat Orthotopic Rhabdomyosarcoma.
Mol Cancer Ther
; 21(10): 1608-1621, 2022 10 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35877472
8.
An optimized bicistronic chimeric antigen receptor against GPC2 or CD276 overcomes heterogeneous expression in neuroblastoma.
J Clin Invest
; 132(16)2022 08 15.
Artigo
Inglês
| MEDLINE | ID: mdl-35852863
9.
Systematic proteome analysis identifies transcription factor YY1 as a direct target of miR-34a.
J Proteome Res
; 10(2): 479-87, 2011 Feb 04.
Artigo
Inglês
| MEDLINE | ID: mdl-21182263
10.
Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma.
Cell Rep Med
; 5(5): 101586, 2024 May 21.
Artigo
Inglês
| MEDLINE | ID: mdl-38723625
11.
Immunotherapy of acute myeloid leukaemia: development of a whole cell vaccine.
Front Biosci
; 13: 2022-9, 2008 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-17981688
12.
Role of 4-1BB:4-1BB ligand in cancer immunotherapy.
Cancer Gene Ther
; 11(3): 215-26, 2004 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-14671675
13.
CLPTM1L promotes growth and enhances aneuploidy in pancreatic cancer cells.
Cancer Res
; 74(10): 2785-95, 2014 May 15.
Artigo
Inglês
| MEDLINE | ID: mdl-24648346
14.
Targeting wild-type and mutationally activated FGFR4 in rhabdomyosarcoma with the inhibitor ponatinib (AP24534).
PLoS One
; 8(10): e76551, 2013.
Artigo
Inglês
| MEDLINE | ID: mdl-24124571
15.
Massively parallel sequencing reveals an accumulation of de novo mutations and an activating mutation of LPAR1 in a patient with metastatic neuroblastoma.
PLoS One
; 8(10): e77731, 2013.
Artigo
Inglês
| MEDLINE | ID: mdl-24147068
16.
Screening a panel of drugs with diverse mechanisms of action yields potential therapeutic agents against neuroblastoma.
Cancer Biol Ther
; 8(24): 2386-95, 2009 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-19946221
17.
microRNA profiling identifies cancer-specific and prognostic signatures in pediatric malignancies.
Clin Cancer Res
; 15(17): 5560-8, 2009 Sep 01.
Artigo
Inglês
| MEDLINE | ID: mdl-19706822
18.
Anti-tumor immunity in a model of acute myeloid leukemia.
Leuk Lymphoma
; 50(3): 447-54, 2009 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-19197726
19.
Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models.
J Clin Invest
; 119(11): 3395-407, 2009 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-19809159
20.
Human neuroblastoma cells rapidly enter cell cycle arrest and apoptosis following exposure to C-28 derivatives of the synthetic triterpenoid CDDO.
Cancer Biol Ther
; 7(5): 709-17, 2008 May.
Artigo
Inglês
| MEDLINE | ID: mdl-18277094